I didn't misread the document, but you seem to want to misrepresent it. True, they haven't yet prescribed to 20,000; but the trial aims to enrol 20,000 and they are selected to provide the product which would infer a steady stream of prescriptions going forward from here for the trial alone.
To clarify further though, the announcement says: "Multiple patients have now been scripted Althea medicinal cannabis in theUK, with a substantial pipeline of patients under assessment for furtherprescriptions"
That is more than one.
Not sure how the partnership with Cannvalate is bringing in the big boys. My reading of this announcement is that their involvement is primarily provision of product in the UK. Althea is the company who has done the hard work, and has the platform that gets doctors educated and able to prescribe.
- Forums
- ASX - By Stock
- Ann: Althea Supplies First UK Patient
I didn't misread the document, but you seem to want to...
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AGH (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.7¢ |
Change
0.002(8.00%) |
Mkt cap ! $10.94M |
Open | High | Low | Value | Volume |
2.5¢ | 2.7¢ | 2.5¢ | $45.16K | 1.746M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 1010657 | 2.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.7¢ | 786608 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 1010657 | 0.026 |
3 | 1030363 | 0.025 |
2 | 1250000 | 0.024 |
4 | 597578 | 0.023 |
3 | 122000 | 0.022 |
Price($) | Vol. | No. |
---|---|---|
0.027 | 749608 | 4 |
0.028 | 765000 | 2 |
0.029 | 210310 | 2 |
0.030 | 448798 | 5 |
0.031 | 528864 | 3 |
Last trade - 14.32pm 13/09/2024 (20 minute delay) ? |
Featured News
AGH (ASX) Chart |
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online